Barbara Klencke, M.D.

Barbara Klencke, M.D.

DirectoratTScan Therapeutics· In proxies 2023–2025

Barbara Klencke, M.D. sits on 4 public boards.

Boards1

  • TScan TherapeuticsDirector · 2 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. TScan TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -87%
  2. Immune-Onc Therapeutics, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  3. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  4. eFFECTOR Therapeutics, Inc.Public company · 3 yr
    • Director2021 – 2024 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?